Dr. Robert L Barkin is Professor of Anesthesiology, Pharmacology, and Family Medicine at Rush University Medical College in Chicago, Illinois. He is also a clinical pharmacologist in a collaborative practice with 5 physician pain specialists at the NorthShore University Health System Department of Anesthesiology Pain Center's of Skokie and Evanston Hospitals in Illinois. Dr. Barkin's extensive daily practice is both outpatient and in-patient. Dr. Barkin designs patient specific pharmacotherpeutic treatment plans. Following graduation from St. Louis College of Pharmacy, Dr. Barkin earned a Master of Business Administration degree in Healthcare Administration from DePaul University in Chicago, Illinois. He then
Dr. Robert L Barkin is Professor of Anesthesiology, Pharmacology, and Family Medicine at Rush University Medical College in Chicago, Illinois. He is also a clinical pharmacologist in a collaborative practice with 5 physician pain specialists at the NorthShore University Health System Department of Anesthesiology Pain Center's of Skokie and Evanston Hospitals in Illinois. Dr. Barkin's extensive daily practice is both outpatient and in-patient. Dr. Barkin designs patient specific pharmacotherpeutic treatment plans. Following graduation from St. Louis College of Pharmacy, Dr. Barkin earned a Master of Business Administration degree in Healthcare Administration from DePaul University in Chicago, Illinois. He then earned his Doctor of Clinical Pharmacy degree from Purdue University in West Lafayette, Indiana. Dr. Barkin is the author of more than 150 abstracts, CD-Rom programs, textbook chapters, and peer reviewed articles. He is Associate Editor for the American Journal of Therapeutics. He also serves as a reviewer for 30 peer-reviewed journals and on the Editorial Board of 11 peer reviewed journals. He is frequently invited to speak on a wide variety of topics at both national and international conferences and seminars. Dr. Barkin is a Diplomate of the American Academy of Pain Management, a Fellow of the American College of Clinical Pharmacology, Diplomate of American Board of Forensic Medicine, Examiners, Psychologic Specialties in Psychopharmacology. Dr. Barkin was granted Scientific status with the American Academy of Pain Medicine.
Prof Nicola Magnavita has received his M.D. and specialization in occupational health in the Universita' Cattolica del Sacro Cuore of Rome during the period of 1971-1980. Currently, he is working as Aggregate Professor of Occupational Health in the Department of Public Health of the same University. His research has included several aspects of occupational medicine and public health; the main scientific interest is the study of hazardous workers and the definition of best practices in occupational medicine. He is serving as an editorial member of several reputed journals like Psychiatry Journal, Annals of Nursing and Practice, Annals of Forensic Research
Prof Nicola Magnavita has received his M.D. and specialization in occupational health in the Universita' Cattolica del Sacro Cuore of Rome during the period of 1971-1980. Currently, he is working as Aggregate Professor of Occupational Health in the Department of Public Health of the same University. His research has included several aspects of occupational medicine and public health; the main scientific interest is the study of hazardous workers and the definition of best practices in occupational medicine. He is serving as an editorial member of several reputed journals like Psychiatry Journal, Annals of Nursing and Practice, Annals of Forensic Research and Analysis, Journal of Emergency Medicine; & expert reviewers for many international journals. He has authored more than 200 research articles/books.
Dr. John A Dani received his Ph.D. in Physiology from the University of Minnesota. After postdoctoral training, he joined Baylor College of Medicine where he became Professor and Director of the Center on Addiction, Learning, and Memory. Dr. Dani has received a number of awards, including the New Investigator Research Award and the Jacob Javits Neuroscience Award from the NIH. During the summer of 2013 he became the Chair of the Department of Neuroscience and Director of the Mahoney Institute for Neurosciences at the Perelman School of Medicine, University of Pennsylvania. Research Interests includes Drug Addiction, Tobacco and Alcohol Abuse,
Dr. John A Dani received his Ph.D. in Physiology from the University of Minnesota. After postdoctoral training, he joined Baylor College of Medicine where he became Professor and Director of the Center on Addiction, Learning, and Memory. Dr. Dani has received a number of awards, including the New Investigator Research Award and the Jacob Javits Neuroscience Award from the NIH. During the summer of 2013 he became the Chair of the Department of Neuroscience and Director of the Mahoney Institute for Neurosciences at the Perelman School of Medicine, University of Pennsylvania. Research Interests includes Drug Addiction, Tobacco and Alcohol Abuse, Synaptic Plasticity and Learning Behaviors, Dopamine Mechanisms and Signaling, Neurophysiology and Electrophysiology, Nicotinic Acetylcholine Receptor Function.
Zsolt Demetrovics, PhD, DSc, is clinical psychologist and cultural anthropologist. Zsolt Demetrovics is professor of psychology at the Eotvos Lorand University, Budapest, Hungary where he serves as director of the Institute of Psychology and head of the Department of Clinical Psychology & Addiction. He has published numerous research papers on the epidemiology and psychological background of substance use behavior and behavioral addictions including gambling, online gaming, internet addiction, exercise addiction, compulsive buying.
Zsolt Demetrovics, PhD, DSc, is clinical psychologist and cultural anthropologist. Zsolt Demetrovics is professor of psychology at the Eotvos Lorand University, Budapest, Hungary where he serves as director of the Institute of Psychology and head of the Department of Clinical Psychology & Addiction. He has published numerous research papers on the epidemiology and psychological background of substance use behavior and behavioral addictions including gambling, online gaming, internet addiction, exercise addiction, compulsive buying.
Deborah R Tasat is a Professor in the Center for the Study of Health and the Environment at the School of Science and Technology of the Universtity of San Martin (UNSAM) and Professor of Histology and Embriology at the Dentistry School of the University of Buenos Aires, Argentina. She worked for the National Commission of Atomic Energy, at Buenos Aires Argentina, was appointed as a visiting scientist at the University of Colorado Springs at Colorado Springs, CO, USA and a as staff member for the Department of Environmental Health, Harvard School of Public Health, MA, USA. Her research interest is primarily
Deborah R Tasat is a Professor in the Center for the Study of Health and the Environment at the School of Science and Technology of the Universtity of San Martin (UNSAM) and Professor of Histology and Embriology at the Dentistry School of the University of Buenos Aires, Argentina. She worked for the National Commission of Atomic Energy, at Buenos Aires Argentina, was appointed as a visiting scientist at the University of Colorado Springs at Colorado Springs, CO, USA and a as staff member for the Department of Environmental Health, Harvard School of Public Health, MA, USA. Her research interest is primarily in the area of Environmental health and toxicology caused by air pollution in urban areas, ashes in rural areas, dusts in certain occupations, and by metallic mico and nanoparticles. Her diverse research activities include: 1) Particle Health Effects; 2) Physico-chemical and toxicological characterization of micro and nanoparticles; 3) Tribocorrosion of metallic biomedical devices and the study of the implant particle- tissue interfaces.
Lawrence Lam has received training in areas of Medical Sciences, Psychology, Public Health, Epidemiology and Medical Statistics. He had worked as a hospital Epidemiologist and a Medical Statistician in the Royal Alexandra Hospital for Children, Sydney, Australia, for many years. He was also the Head of Epidemiology and Medical Statistics, as well as the Deputy Chair of the Population and Public Health Domain in the School of Medicine Sydney, the University of Notre Dame Australia. He is also appointed a Fellow of the American College of Epidemiology. Being an Epidemiologist, a Statistician, and a research Psychologist in clinical and academic
Lawrence Lam has received training in areas of Medical Sciences, Psychology, Public Health, Epidemiology and Medical Statistics. He had worked as a hospital Epidemiologist and a Medical Statistician in the Royal Alexandra Hospital for Children, Sydney, Australia, for many years. He was also the Head of Epidemiology and Medical Statistics, as well as the Deputy Chair of the Population and Public Health Domain in the School of Medicine Sydney, the University of Notre Dame Australia. He is also appointed a Fellow of the American College of Epidemiology. Being an Epidemiologist, a Statistician, and a research Psychologist in clinical and academic settings, Lawrence has experience in many different sub-specialties in Epidemiology and Medicine. He has been researching consistent in the area child and adolescent mental health and risky behaviours, particularly addictive behaviours. He has been focusing on Problematic Internet Use and Problematic Internet Gaming within the East Asia Region.
At 7 years, I was sent to St. Joseph's College (school), North Point, Darjeeling, and from 15-17 years I attended Wallington Grammar School, Wallington, Surrey, UK. During this time I was part-time stable lad, Epsom, Surrey. With 'O'-levels, I was offered a position at the Institute of Animal Physiology, Babraham, UK, and took my HND qualification at Cambridge Polytechnical College, Cambridge, UK (1971). Thereafter, I obtained an Honour's degree (Psychology and Physiology) at Newcastle-upon-Tyne University (1974), and a PhD, Uppsala University, Uppsala, Sweden (1979). From 1978 (Aug) to 1988 (Dec), I was employed by Astra Lakemedel AB with the position
At 7 years, I was sent to St. Joseph's College (school), North Point, Darjeeling, and from 15-17 years I attended Wallington Grammar School, Wallington, Surrey, UK. During this time I was part-time stable lad, Epsom, Surrey. With 'O'-levels, I was offered a position at the Institute of Animal Physiology, Babraham, UK, and took my HND qualification at Cambridge Polytechnical College, Cambridge, UK (1971). Thereafter, I obtained an Honour's degree (Psychology and Physiology) at Newcastle-upon-Tyne University (1974), and a PhD, Uppsala University, Uppsala, Sweden (1979). From 1978 (Aug) to 1988 (Dec), I was employed by Astra Lakemedel AB with the position of Head of CNS Drugs when I left to take up my appointment as Professor and Chair of Biological Psychology. I have the position of Guest or Visiting Professor at: University of Hawaii at Manoa, Orebro University, Karlstad University, Kalmar University, Madrid University and received an Outstanding Lifetime Achievement Award from St. Joseph's College, North Point (2010); Honorary Doctorship,: Professorship and Membership Awards from the Polish Academy of Science Pharmacological Society (may, 2013); and the Sansone Award (April, 2014): School of Medicine, Washington University, St. Louis, Missouri.
Douglas L Polcin, Ed.D.is a Senior Scientist at the Alcohol Research Group in Emeryville, California. He has been the principal investigator on a variety of National Institute of Health grants studying motivational interviewing, sober living recovery homes, supportive confrontation,and treatment for criminal justice offenders. Dr. Polcin has also worked as a clinician and supervisor in avariety of substance abuse and mental health programs since 1979. His clinical experiences include positions at programs affiliated with the Cambridge Hospital Department of Psychiatry in Massachusetts and the department of psychiatry at San Francisco General Hospital.
Douglas L Polcin, Ed.D.is a Senior Scientist at the Alcohol Research Group in Emeryville, California. He has been the principal investigator on a variety of National Institute of Health grants studying motivational interviewing, sober living recovery homes, supportive confrontation,and treatment for criminal justice offenders. Dr. Polcin has also worked as a clinician and supervisor in avariety of substance abuse and mental health programs since 1979. His clinical experiences include positions at programs affiliated with the Cambridge Hospital Department of Psychiatry in Massachusetts and the department of psychiatry at San Francisco General Hospital.
In 1995 Dr. Blum retired from the University Of Texas Health Science Center giving up tenure to enter the world of business and biotechnology. In the second year, acting as manager of 1899 Limited Liability Corporation, his first weight management product grossed in excess of 60 million retail. His company Cyberpharm has launched a weight loss system with Rexall/Showcase which was launched early 1999. Dr. Blum continues to publish research articles, writes books (twelve), lectures, and is actively applying for numerous patents in the field of molecular genetics & nutrition. Dr. Blum is very active as Scientific Director of the
In 1995 Dr. Blum retired from the University Of Texas Health Science Center giving up tenure to enter the world of business and biotechnology. In the second year, acting as manager of 1899 Limited Liability Corporation, his first weight management product grossed in excess of 60 million retail. His company Cyberpharm has launched a weight loss system with Rexall/Showcase which was launched early 1999. Dr. Blum continues to publish research articles, writes books (twelve), lectures, and is actively applying for numerous patents in the field of molecular genetics & nutrition. Dr. Blum is very active as Scientific Director of the Path Medical Foundation and former co-founder and Vice President of the American College of Addictionology and Compulsive Disorders. Dr. Blum is co-founder and Chairman & CSO of Impact Genomics and Managing Partner of IGENE, LLC. He was former Chief Scientific Officer of G&G HealthCare Services, Inc. and Genomics HealthCare, LLC. His concept of Reward Deficiency Syndrome is being embraced by world leaders in science and is part of the DSM -V, ASAM and the DRD2 gene discovery has been confirmed in over 4,000 publications from laboratories all over the world. Currently he has been named Volunteer Full Professor of the Department of Psychiatry & McKnight Brain Institute University of Florida College of Medicine, Gainesville, Florida and Adjunct Research Professor, Human Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT. He currently serves as neuroscience advisor for Dominion Diagnostics, LLC North Kingstown Rhode Island; and Malibu Beach Recovery Center, Malibu Beach, California. Many consider him as the 'Father of Psychiatric Genetics' and 'Father of Neuro- Nutrient Therapy'. Dr. Blum received the Life Time Achievement Award from the National Institute of Holistic Addiction Studies 2011, the 2012 Scientific Achievement Award in a Gala Celebrity Event, Miami Beach Florida and Best Abstract Award from the American Society of Anesthesiology and Pain. He is the 2014 recipient of the American Society of Medicine (ASAM) Millennium Lab Award.He and Mark Gold recently signed with Springer as Series editor for Neuroscience of Addiction: A Reference Work which includes four volumes to be published in 2015. Us patents issued include 6,132724, 6,9558873 and others. European patents include EP0979092 and others. Patents pending include RDS patentsUS11/250,355;US61/154,501, two Pain patent applications (provisional) #'s 61074629, 61074630 and US patent issued H-Wave device. The total number of patents in the US and abroad amount to north of 20.Dr. Blum is the prime inventor of anti craving natural Dopamine D2 agonist therapy including SynaptagenX, Brain Reward, as well as other related commercial products in the United States.
A Kenison Roy, III, MD is founder and medical director of the Dual Diagnosis Unit at River Oaks Hospital in Harahan, LA and president and medical director of Biobehavioral Medicine Company, LLC in Metairie, LA. He also is medical director of Addiction Recovery Resources of New Orleans also in Metairie, and has had a successful adult addiction and psychiatric private practice for over 25 years. Dr. Roy is Clinical Associate Professor of Psychiatry at Tulane School of Medicine, a Distinguished Fellow of the American Psychiatric Association, Fellow of the American Society of Addiction Medicine and is certified by the American
A Kenison Roy, III, MD is founder and medical director of the Dual Diagnosis Unit at River Oaks Hospital in Harahan, LA and president and medical director of Biobehavioral Medicine Company, LLC in Metairie, LA. He also is medical director of Addiction Recovery Resources of New Orleans also in Metairie, and has had a successful adult addiction and psychiatric private practice for over 25 years. Dr. Roy is Clinical Associate Professor of Psychiatry at Tulane School of Medicine, a Distinguished Fellow of the American Psychiatric Association, Fellow of the American Society of Addiction Medicine and is certified by the American Board of Psychiatry and Neurology and the American Board of Addiction Medicine. He also is a member of the American Academy of Addiction Psychiatry and the American Medical Association.
Fatih Canan, MD, is an associate professor at the Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey. He also serves as a consultant in Akdeniz University Center on Alcohol and Substance Research and Treatment. His major current research focus is on the biochemical and genetic correlates of heroin dependence. His other research interest is behavioral addictions, particularly Internet addiction. He has published several papers on Internet addiction. He has been an active reviewer in many international journals in the areas of psychiatry and psychopharmacology.
Fatih Canan, MD, is an associate professor at the Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey. He also serves as a consultant in Akdeniz University Center on Alcohol and Substance Research and Treatment. His major current research focus is on the biochemical and genetic correlates of heroin dependence. His other research interest is behavioral addictions, particularly Internet addiction. He has published several papers on Internet addiction. He has been an active reviewer in many international journals in the areas of psychiatry and psychopharmacology.
Mauro CECCANTI is Associate Professor at University La Sapienza, Rome. he submitted 353 scientific papers and given 115 congresses talks, and edited about 30 books. He received awards in 1990: Crescendo Award for scientific activity. 1990: Cavaliere of Italian Republic for scientific excellence.He is expert member of 2008- European Medicines Agency, 2008- European Alcohol and Health Forum, 2005- Italian Government for Drug Addiction, NATIONAL PROJECT GRANTS. More than 30 research grants and contracts with public and private foundations.
Mauro CECCANTI is Associate Professor at University La Sapienza, Rome. he submitted 353 scientific papers and given 115 congresses talks, and edited about 30 books. He received awards in 1990: Crescendo Award for scientific activity. 1990: Cavaliere of Italian Republic for scientific excellence.He is expert member of 2008- European Medicines Agency, 2008- European Alcohol and Health Forum, 2005- Italian Government for Drug Addiction, NATIONAL PROJECT GRANTS. More than 30 research grants and contracts with public and private foundations.
Xiu Liu, MD, PhD, Associate Professor in Department of Psychiatry and Human Behavior at University of Mississippi Medical Center, his research interests are Animal models of nicotine-taking/-seeking behavior are used to investigate neurobiological mechanisms of nicotine addiction. Projects require rat-loving persons since on a daily basis rats are handled, weighed, fed and trained to perform certain behavior.
Xiu Liu, MD, PhD, Associate Professor in Department of Psychiatry and Human Behavior at University of Mississippi Medical Center, his research interests are Animal models of nicotine-taking/-seeking behavior are used to investigate neurobiological mechanisms of nicotine addiction. Projects require rat-loving persons since on a daily basis rats are handled, weighed, fed and trained to perform certain behavior.
Dr. Guillaume B Fond is an Associate Professor of Psychiatry at University at Paris-Est, Assistant Professor at Ecole Montsouris, and is serving as Psychiatrist at Creteil Schizophrenia Expert Center and at Psychiatry and Addictology department (Pr Leboyer), Creteil, France. He coordinates the Schizophrenia Expert Centers Network and the FACE-SZ cohort with Pr Llorca, Clermont-Ferrand, France. He graduated from Lyon 1 University with the degrees of MBBS, MD along with Montpellier University. He worked for 2 years as chef de Clinique assistant des hopitaux in Montpellier, France. Dr. Fond is a member of various societies including Fondation Fondamental and Association pour
Dr. Guillaume B Fond is an Associate Professor of Psychiatry at University at Paris-Est, Assistant Professor at Ecole Montsouris, and is serving as Psychiatrist at Creteil Schizophrenia Expert Center and at Psychiatry and Addictology department (Pr Leboyer), Creteil, France. He coordinates the Schizophrenia Expert Centers Network and the FACE-SZ cohort with Pr Llorca, Clermont-Ferrand, France. He graduated from Lyon 1 University with the degrees of MBBS, MD along with Montpellier University. He worked for 2 years as chef de Clinique assistant des hopitaux in Montpellier, France. Dr. Fond is a member of various societies including Fondation Fondamental and Association pour lenseignement de la semiologie Psychiatrique (AESP). He is a researcher at the Inserm U955 eq 15, DHU Pe-Psy, Creteil, France. He has authored more than 40 peer reviewed journal articles and has the credit of more than 10 presentations. Research interest includes schizophrenia, inflammation, microbiota, Toxoplasma, tobacco consumption, neuroenhancement, psychostimulants.
Jose Carlos F Galduroz, MD, Ph.D is Associate Professor at Department of Psychobiology of Federal University of Sao Paulo - Brazil. Has experience in Public Health with emphasis in Health Sciences, acting on the following topics: drug abuse, epidemiology, psychoactive drugs, addiction, prevention and treatment. Currently is dedicated to the study of craving and impulsivity both in basic research as clinical research. Reviewer for 44 scientific journals and ad hoc consultant FAPESP (Foundation for Research Support of the State of São Paulo - Brazil) and CNPq (National Research Council - Brazil). Membership (RSA) - Research Society on Alcoholism since 2010.
Jose Carlos F Galduroz, MD, Ph.D is Associate Professor at Department of Psychobiology of Federal University of Sao Paulo - Brazil. Has experience in Public Health with emphasis in Health Sciences, acting on the following topics: drug abuse, epidemiology, psychoactive drugs, addiction, prevention and treatment. Currently is dedicated to the study of craving and impulsivity both in basic research as clinical research. Reviewer for 44 scientific journals and ad hoc consultant FAPESP (Foundation for Research Support of the State of São Paulo - Brazil) and CNPq (National Research Council - Brazil). Membership (RSA) - Research Society on Alcoholism since 2010. He has published 73 scientific articles indexed in PubMed, among others.
Dr. Giovanni Martinotti is currently Senior Researcher in Psychiatry and Academic Lead of the Research Unit on Addiction at the Department of Neuroscience and Imaging, University G.d'Annunzio of Chieti-Pescara. In his career he has developed a strong clinic and academic expertise in the field of substance abuse, as well as other forms of addiction including pathologic gambling and behavioural addictions. He is author/coauthor of more than 180 papers on peer-reviewed journals with impact factor and he has published 11 books as editor and 1 monograph. He is also associate editor of different scientific journals. He has recently been elected president
Dr. Giovanni Martinotti is currently Senior Researcher in Psychiatry and Academic Lead of the Research Unit on Addiction at the Department of Neuroscience and Imaging, University G.d'Annunzio of Chieti-Pescara. In his career he has developed a strong clinic and academic expertise in the field of substance abuse, as well as other forms of addiction including pathologic gambling and behavioural addictions. He is author/coauthor of more than 180 papers on peer-reviewed journals with impact factor and he has published 11 books as editor and 1 monograph. He is also associate editor of different scientific journals. He has recently been elected president of the Young Section of the Italian Society of Psychiatry. He is committed to knowledge exchange and information dissemination regarding Novel Psychoactive Substances (NPS): he is Lecturer in both undergraduate and postgraduate courses in different Universities, and he is often invited as a contributor to national and international conferences, especially focused on addiction and substances of abuse.
Fiorenzo Laghi received his doctoral degree from Sapienza University in Psychology in 2003. He is Assistant Professor of Developmental Psychology (SSD: M-PSI/04). His primary research interests focus on prevention of risk behaviors and promotion of positive outcomes for at-risk child and adolescent populations. One area of research examines protective and risk factors on the development of risk behavior (i.e., substance use, binge drinking and binge eating) among at-risk early-adolescent and adolescent populations, and also involves the development and testing of programs to prevent or reduce involvement in such behaviors. He also has interests in the application of advanced multivariate
Fiorenzo Laghi received his doctoral degree from Sapienza University in Psychology in 2003. He is Assistant Professor of Developmental Psychology (SSD: M-PSI/04). His primary research interests focus on prevention of risk behaviors and promotion of positive outcomes for at-risk child and adolescent populations. One area of research examines protective and risk factors on the development of risk behavior (i.e., substance use, binge drinking and binge eating) among at-risk early-adolescent and adolescent populations, and also involves the development and testing of programs to prevent or reduce involvement in such behaviors. He also has interests in the application of advanced multivariate data analytic methods to examine identity status and risk and protective processes associated with developmental processes in behavioral outcomes. He is Director of Master in Autism Spectrum Disorder at Sapienza, University of Rome.
Nilkantha Sen is an Assistant Professor at Georgia Health Science University, Augusta, GA. He completed his Ph.D from Indian institute of Chemical Biology, India. He received honor of Young Scientist Award (W Barry Wood, Jr) from Johns Hopkins University, USA. Dr. Sen active editorial board member in Neuromolecular Medicine, American Journal of Neuroscience Research, Neurology and Neurotechnology, International Journal of Neurology Research. His research interest on a major barrier to successfully treating cocaine addiction is the high rate of drug relapse that occurs during periods of drug withdrawal. However, to date there are no FDA approved pharmacotherapies to
Nilkantha Sen is an Assistant Professor at Georgia Health Science University, Augusta, GA. He completed his Ph.D from Indian institute of Chemical Biology, India. He received honor of Young Scientist Award (W Barry Wood, Jr) from Johns Hopkins University, USA. Dr. Sen active editorial board member in Neuromolecular Medicine, American Journal of Neuroscience Research, Neurology and Neurotechnology, International Journal of Neurology Research. His research interest on a major barrier to successfully treating cocaine addiction is the high rate of drug relapse that occurs during periods of drug withdrawal. However, to date there are no FDA approved pharmacotherapies to treat cocaine addiction. Behavioral-stimulant effects of cocaine are thought to be initiated by potentiation of the synaptic actions of dopamine and, possibly, serotonin associated with inhibition of neurotransmitter transport. In our laboratory we study the influence of neuro-gasotransmitters like Nitric Oxide (NO), on drug addiction and synaptic plasticity in brain. Our study will provide the framework to design a novel therapeutic strategy to combat against addiction against drug-of-abuse.
Dr. Christopher Ochner completed his PhD in clinical psychology at Drexel University in Philadelphia in 2006. He then completed an individual NIH grant fellowship at the Columbia University Institute of Human Nutrition/New York Obesity Nutrition Research Center. In 2009, he received an NIH career development award and was promoted to faculty at the Columbia University College of Physicians & Surgeons. He became the youngest Columbia faculty to run an independent research laboratory, publishing >20 peer-reviewed articles since 2009. He has served as a mentor for graduate students, fullbright scholars, residents and fellows. Now, as faculty
Dr. Christopher Ochner completed his PhD in clinical psychology at Drexel University in Philadelphia in 2006. He then completed an individual NIH grant fellowship at the Columbia University Institute of Human Nutrition/New York Obesity Nutrition Research Center. In 2009, he received an NIH career development award and was promoted to faculty at the Columbia University College of Physicians & Surgeons. He became the youngest Columbia faculty to run an independent research laboratory, publishing >20 peer-reviewed articles since 2009. He has served as a mentor for graduate students, fullbright scholars, residents and fellows. Now, as faculty at the Icahn School of Medicine at Mount Sinai and Director of Research Training and Development at the Mount Sinai Adolescent Health Center, Dr. Ochner is working to develop a clinically-based program of research in the area of obesity prevention and treatment, as well as fostering the development of research in other areas within the Mount Sinai Adolescent Health Center of the Icahn School of Medicine at Mount Sinai.
Frederico C Pereira graduated in Biochemistry at the University of Coimbra, Portugal and completed his PhD in 2007 at Faculty of Medicine University of Coimbra (FMUC). He is assistant professor at FMUC and he is the co-leader of the group Neuropharmacology of Drugs of Abuse from Institute for Biomedical Imaging and Life Sciences (IBILI)/FMUC. He has been characterizing the neurochemical/astroglial dysfunction underlying the behavioural profile of rodent models intoxicated with methamphetamine, which is a very addictive basal ganglia toxin. He is supervising Master is and PhD students. He has published 25 research papers and 3 book chapters.
Frederico C Pereira graduated in Biochemistry at the University of Coimbra, Portugal and completed his PhD in 2007 at Faculty of Medicine University of Coimbra (FMUC). He is assistant professor at FMUC and he is the co-leader of the group Neuropharmacology of Drugs of Abuse from Institute for Biomedical Imaging and Life Sciences (IBILI)/FMUC. He has been characterizing the neurochemical/astroglial dysfunction underlying the behavioural profile of rodent models intoxicated with methamphetamine, which is a very addictive basal ganglia toxin. He is supervising Master is and PhD students. He has published 25 research papers and 3 book chapters.
Chella Kamarajan, PhD, is an assistant professor at the Henri Begleiter Neurodynamics Laboratory, Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, NY, USA. He is an expert in neurophysiology, neuropsychology, and psychopathology. His major current research focus is on understanding the neurophysiological and genetic basis of alcoholism and related disorders. Dr. Kamarajan completed his doctoral and postdoctoral training in clinical psychology (with specialization in neuropsychology and psychophysiology) from the National Institute of Mental Health and Neurosciences, India. He has published several important papers on event-related potentials (ERPs) and brain oscillations in alcoholism. He has been an active
Chella Kamarajan, PhD, is an assistant professor at the Henri Begleiter Neurodynamics Laboratory, Department of Psychiatry and Behavioral Sciences, SUNY Downstate Medical Center, Brooklyn, NY, USA. He is an expert in neurophysiology, neuropsychology, and psychopathology. His major current research focus is on understanding the neurophysiological and genetic basis of alcoholism and related disorders. Dr. Kamarajan completed his doctoral and postdoctoral training in clinical psychology (with specialization in neuropsychology and psychophysiology) from the National Institute of Mental Health and Neurosciences, India. He has published several important papers on event-related potentials (ERPs) and brain oscillations in alcoholism. He has been an active reviewer in many international journals in the areas of psychology, neuroscience, and psychiatry. He is in the editorial boards of five international journals on psychology and neuroscience. He is also a member of numerous professional/scientific organization.
Dr. Vinod K Yaragudri completed his Ph.D in Neurochemistry at National Institute of Mental Health and Neurosciences, Bangalore, India in 2002. He did his postdoctoral research training at Nathan Kline Institute for Psychiatric Research (NKI), Orangeburg, New York. He is currently a Research Scientist at NKI and Research Assistant Professor at the Department of Child and Adolescent Psychiatry, New York School of Medicine. Dr. Yaragudri's research is focused on understanding the role of endocannabinoid system in the neurobiology of depressive and drug abuse disorders (cannabis and alcohol). He has published several peer-reviewed articles in these fields. Dr. Yaragudri's research is
Dr. Vinod K Yaragudri completed his Ph.D in Neurochemistry at National Institute of Mental Health and Neurosciences, Bangalore, India in 2002. He did his postdoctoral research training at Nathan Kline Institute for Psychiatric Research (NKI), Orangeburg, New York. He is currently a Research Scientist at NKI and Research Assistant Professor at the Department of Child and Adolescent Psychiatry, New York School of Medicine. Dr. Yaragudri's research is focused on understanding the role of endocannabinoid system in the neurobiology of depressive and drug abuse disorders (cannabis and alcohol). He has published several peer-reviewed articles in these fields. Dr. Yaragudri's research is funded by both federal and private agencies. Research Interests include Drug abuse, anxiety and mood disorders.
Dr. Christopher B R Smith has worked extensively in the areas of harm reduction and addiction treatment policy, with a particular focus on socio-spatial stigmatization, the biopolitical dimensions of methadone treatment, and direct drug/service user involvement in harm. Having conducted research in Canada, Australia and the U.S. over the past five years, Dr. Smith's work encompasses comparative, international analysis with a diverse global network of research collaborators, including academics, autonomous drug user organizations, front-line harm reduction and addiction treatment service providers and individual drug/service users. Beyond his academic research, Dr. Smith has additionally been involved in numerous relevant professional research
Dr. Christopher B R Smith has worked extensively in the areas of harm reduction and addiction treatment policy, with a particular focus on socio-spatial stigmatization, the biopolitical dimensions of methadone treatment, and direct drug/service user involvement in harm. Having conducted research in Canada, Australia and the U.S. over the past five years, Dr. Smith's work encompasses comparative, international analysis with a diverse global network of research collaborators, including academics, autonomous drug user organizations, front-line harm reduction and addiction treatment service providers and individual drug/service users. Beyond his academic research, Dr. Smith has additionally been involved in numerous relevant professional research consulting endeavors relating to drug policy in Canada, supervised injection site needs assessment studies, and the role and importance of actively engaging people with lived experience in all areas of addiction research and treatment
Barbara Budzynska Bud is a Professor Assistant in the Chair and Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Poland. Her research is focused on behavioral pharmacology, mainly rewarding (including locomotor sensitization, cross-sensitization, place conditioning, and withdrawal syndrome), cognitive and emotional effects of drugs of abuse, including new psychoactive substances, e.g. legal highs. Another research line focuses on the assessment of activity of the furanocoumarins in animal models. She also is a member of the Polish Pharmaceutical Society and the Polish Neuroscience Society.
Barbara Budzynska Bud is a Professor Assistant in the Chair and Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Poland. Her research is focused on behavioral pharmacology, mainly rewarding (including locomotor sensitization, cross-sensitization, place conditioning, and withdrawal syndrome), cognitive and emotional effects of drugs of abuse, including new psychoactive substances, e.g. legal highs. Another research line focuses on the assessment of activity of the furanocoumarins in animal models. She also is a member of the Polish Pharmaceutical Society and the Polish Neuroscience Society.
Matej Kravos, MD, PhD, is an Assistant professor of Psychiatry at the University of Maribor and Faculty of Mathematics, Natural Sciences and Information Technologies, University of Primorska, Slovenia and is a Forensic psychiatrist at The Ministry of Justice of Slovenia. The major research aims is the role of biomarkers as a diagnostic aid in psychiatry. He has 1ongterm experience in application of glutamate dehydrogenase as a diagnostic biomarker. His research was also focused on studies on drugs and its clinical evaluation, implementation of computer based systems for diagnostic decisions and contribution in forensic psychiatry. He is an author of over
Matej Kravos, MD, PhD, is an Assistant professor of Psychiatry at the University of Maribor and Faculty of Mathematics, Natural Sciences and Information Technologies, University of Primorska, Slovenia and is a Forensic psychiatrist at The Ministry of Justice of Slovenia. The major research aims is the role of biomarkers as a diagnostic aid in psychiatry. He has 1ongterm experience in application of glutamate dehydrogenase as a diagnostic biomarker. His research was also focused on studies on drugs and its clinical evaluation, implementation of computer based systems for diagnostic decisions and contribution in forensic psychiatry. He is an author of over 50 different papers covering psychiatry and biochemical markers. The research interests: biomarkers in psychiatry, neurodegenerative, psychotic and affective disorders, addiction and forensic psychiatry.
Dr. Xingbao Li is an Assistant Professor in Department of Psychiatry and Human Behavior at Medical University of South Carolina. He received his M.D. in Clinical Medicine from Jining Medical College and his M.S. in Psychiatry from Chongqing University of Medical Sciences in China. His research interests include transcranial magnetic stimulation (TMS) and neuroimaging in neuropsychiatry, combining TMS and functional MRI techniques in neuropharmacology, functional MRI in alcoholism and other substance abuse, brain stimulation therapy in depression and substance abuse.
Dr. Xingbao Li is an Assistant Professor in Department of Psychiatry and Human Behavior at Medical University of South Carolina. He received his M.D. in Clinical Medicine from Jining Medical College and his M.S. in Psychiatry from Chongqing University of Medical Sciences in China. His research interests include transcranial magnetic stimulation (TMS) and neuroimaging in neuropsychiatry, combining TMS and functional MRI techniques in neuropharmacology, functional MRI in alcoholism and other substance abuse, brain stimulation therapy in depression and substance abuse.
Dr. Eduardo J Perez Pedrero has worked for 29 years in treating people with addictions, both in Professional Therapeutic Community, and in outpatient services. Doctor in Psychology, Master Degree in Drug-Addictions, Diploma in Nursing, and Social Educator. Professor in postgraduate courses in various Spanish universities. He has participated in numerous national and international courses, congresses and conferences as a speaker and organizer. Research on addiction-related areas such as concurrent psychopathology, personality and its disorders, ADHD, quality of life, motivational interviewing, results of treatments or neuropsychology. He has published 35 scientific articles indexed in PubMed, among others. He has written books
Dr. Eduardo J Perez Pedrero has worked for 29 years in treating people with addictions, both in Professional Therapeutic Community, and in outpatient services. Doctor in Psychology, Master Degree in Drug-Addictions, Diploma in Nursing, and Social Educator. Professor in postgraduate courses in various Spanish universities. He has participated in numerous national and international courses, congresses and conferences as a speaker and organizer. Research on addiction-related areas such as concurrent psychopathology, personality and its disorders, ADHD, quality of life, motivational interviewing, results of treatments or neuropsychology. He has published 35 scientific articles indexed in PubMed, among others. He has written books and coordinated collective works on Addiction and Neuroscience and participated in collective books on issues related to addiction. He is on the Editorial Board of the 3 main Spanish addiction magazines. Research Interests: Neuropsychological basis of addiction; Treatment based on empowerment, environmental enrichment and neuropsychological rehabilitation; Addiction Recovery.
Marija Rusaka M.D., Ph.D., currently working as Psychiatrist at Acute Adult (male) Inpatient Department in Riga Centre of Psychiatry and Addiction Disorders, Latvia. She gets Ph.D. degree at Riga Stradins University, Latvia and continue work there as researcher at Department of Psychiatry and Addiction disorder. Her research interests include first episode psychosis (including substance-induced psychosis), aggressive behavioral in patients, health sociology. She is member of Latvian Psychiatrists Association and active member of European College of Neuropsychopharmacology.
Marija Rusaka M.D., Ph.D., currently working as Psychiatrist at Acute Adult (male) Inpatient Department in Riga Centre of Psychiatry and Addiction Disorders, Latvia. She gets Ph.D. degree at Riga Stradins University, Latvia and continue work there as researcher at Department of Psychiatry and Addiction disorder. Her research interests include first episode psychosis (including substance-induced psychosis), aggressive behavioral in patients, health sociology. She is member of Latvian Psychiatrists Association and active member of European College of Neuropsychopharmacology.
Olatz Lopez-Fernandez, PhD, clinical psychologist and specialist in technological uses. She is doctor in educational technology and technological addictions with European mentions, and the second one awarded with the Queen Sofia award against drugs. She is postdoctoral researcher of psychology at the Catholic University of Louvain, Belgium, where she is leading a Marie Curie TECH USE DISORDERS project: cross-cultural research in information and communication technologies. She has published research papers on both expertise, and specifically in drug-addiction (follow-up studies) and technological addictions (reviews, epidemiologic studies, as well as she has created and adapted scales to measure these problematics) including internet
Olatz Lopez-Fernandez, PhD, clinical psychologist and specialist in technological uses. She is doctor in educational technology and technological addictions with European mentions, and the second one awarded with the Queen Sofia award against drugs. She is postdoctoral researcher of psychology at the Catholic University of Louvain, Belgium, where she is leading a Marie Curie TECH USE DISORDERS project: cross-cultural research in information and communication technologies. She has published research papers on both expertise, and specifically in drug-addiction (follow-up studies) and technological addictions (reviews, epidemiologic studies, as well as she has created and adapted scales to measure these problematics) including internet addiction, video game addiction and mobile phone addiction.
Felice Nava is Medical Doctor and specialist both in Clinical Pharmacology and Psychotherapy. He is also PhD in Neuroscience. At the beginning of his career he worked as post-doc at the Department of Neuroscience, University of Cagliari, at the Department of Pharmacology, University of London and at the Lab of Neuropsychopharmacology, University of California at Irvine. Today his research and clinical interests are on the neurobiology of addiction, pharmacotherapy of drug abuse, and penitentiary medicine. He is teaching of neurobiology of addiction at Universities of Padua, Modena and Verona. He is author of 36 full papers published in peer-reviewed journals
Felice Nava is Medical Doctor and specialist both in Clinical Pharmacology and Psychotherapy. He is also PhD in Neuroscience. At the beginning of his career he worked as post-doc at the Department of Neuroscience, University of Cagliari, at the Department of Pharmacology, University of London and at the Lab of Neuropsychopharmacology, University of California at Irvine. Today his research and clinical interests are on the neurobiology of addiction, pharmacotherapy of drug abuse, and penitentiary medicine. He is teaching of neurobiology of addiction at Universities of Padua, Modena and Verona. He is author of 36 full papers published in peer-reviewed journals and 27 articles in non-peer-reviewed journals, 8 books, 28 chapters of books, and 70 congress communications. He was director of the national scientific committee of the Italian Society of Addiction Medicine (FeDerSerD). Actually, Felice Nava is Vice-President of FeDerSerD and director of the Penitentiary Medicine in Padua.
Dr. Subin Park received her medical training at the Chung Ang University College of Medicine and completed her residency as a psychiatrist at the Asan Medical Center. She received further clinical and research training at the Department of Psychiatry, Asan Medical Center and the Department of Child and Adolescent Psychiatry, Seoul National University Hospital. She currently is on the psychiatry staff at Seoul National Hospital. She has published 70 scientific articles indexed in PubMed. Her current major research interests include child and adolescent psychopathology including addictive behaviors.
Dr. Subin Park received her medical training at the Chung Ang University College of Medicine and completed her residency as a psychiatrist at the Asan Medical Center. She received further clinical and research training at the Department of Psychiatry, Asan Medical Center and the Department of Child and Adolescent Psychiatry, Seoul National University Hospital. She currently is on the psychiatry staff at Seoul National Hospital. She has published 70 scientific articles indexed in PubMed. Her current major research interests include child and adolescent psychopathology including addictive behaviors.
Graduated in Psychology at University of Sao Paulo (2008). Received the award of the best student graduated in Psychology in 2008. PhD in Clinical Psycholoy at University of Sao Paulo (2015). Worked with drug abuse and animal models of dependency. Studied Clinical Psychology and has experience in clinical treatments for drug abuse. Works as Senior Researcher and Clinical Private Practice.
Graduated in Psychology at University of Sao Paulo (2008). Received the award of the best student graduated in Psychology in 2008. PhD in Clinical Psycholoy at University of Sao Paulo (2015). Worked with drug abuse and animal models of dependency. Studied Clinical Psychology and has experience in clinical treatments for drug abuse. Works as Senior Researcher and Clinical Private Practice.
Patryk Piotrowski an experienced, creative and hard-working researcher with wide range of interests. Concurrently with medical studies I graduated in Management and Administration in Health Care. My knowledge in health care economics allowed me defence of doctoral thesis - Assessment of costs of mental health care in Poland on the basis of CEA method cum laude. I was also a beneficent of scholarships of Polish Psychiatric Association, WHO's International Center of Mental Health Policy and Economics and UE's Programme UDA-POKL.04.01.01-00-010/08-01, Ulm University etc. I have published several chapters i.a.: Modeling and reconstructing mental health care: viewpoint and discussion in Operational
Patryk Piotrowski an experienced, creative and hard-working researcher with wide range of interests. Concurrently with medical studies I graduated in Management and Administration in Health Care. My knowledge in health care economics allowed me defence of doctoral thesis - Assessment of costs of mental health care in Poland on the basis of CEA method cum laude. I was also a beneficent of scholarships of Polish Psychiatric Association, WHO's International Center of Mental Health Policy and Economics and UE's Programme UDA-POKL.04.01.01-00-010/08-01, Ulm University etc. I have published several chapters i.a.: Modeling and reconstructing mental health care: viewpoint and discussion in Operational Research Applied to Health Services in Action, ed. by Marek Lubicz (ISBN: 978-1-61324-353-4) and Socioeconomic Factors and Mental Healthcare in Social Determinants and Mental Health, ed. Sabine Bahrer-Kohler (ISBN: 978-1-61324-353-4) and numerous papers in international journals. My last field of interest are health economics, epidemiology and public health.
Dr. Philippe Nubukpo, served as a Hospital practitioner, psychiatrist at Centre Hospitalier Esquirol in Limoges and as researcher in UMR/INSERM 1094 / Faculty of medicine. He holds a habilitation to supervise research (HDR) of the University of Limoges (2007-10-18), a PhD degree (public health), a master degree (DEA) in public health (Paris VI), a Masters of biological science and medicine (MSBM); He has the ordinal qualification in Psychiatry (03/09/2003), and holds addiction medicine degree (25/09/2012) and Gerontology medicine degree as well as pedagogy qualification. Its research activities are conducted within the unit INSERM 1094 Neuro epidemiology tropical (NET) of
Dr. Philippe Nubukpo, served as a Hospital practitioner, psychiatrist at Centre Hospitalier Esquirol in Limoges and as researcher in UMR/INSERM 1094 / Faculty of medicine. He holds a habilitation to supervise research (HDR) of the University of Limoges (2007-10-18), a PhD degree (public health), a master degree (DEA) in public health (Paris VI), a Masters of biological science and medicine (MSBM); He has the ordinal qualification in Psychiatry (03/09/2003), and holds addiction medicine degree (25/09/2012) and Gerontology medicine degree as well as pedagogy qualification. Its research activities are conducted within the unit INSERM 1094 Neuro epidemiology tropical (NET) of the University of Limoges, within the thematic axis dementia and neurodegenerative diseases and the theme epilepsy. He has implemented the addiction medicine department to the CH Esquirol and CHU of Limoges. He teaches both Psychiatry, addiction and psychotherapy.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97